• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Telehealth App Approved By NHS to Deliver Prescriptions to UK Patients

by HITC Staff 06/30/2015 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Telehealth App Approved By NHS to Deliver Prescriptions to UK PatientsDr Now, a telehealth app that dispenses and deliver prescriptions directly to patients’ home or office has been approved by NHS England to handle NHS prescriptions using the NHS Electronic Prescription Service. Now available for Apple and Android devices, Dr Now offers instant access to UK registered doctors through video-based consultation, with NHS prescriptions dispensed and delivered in central London and overnight nationwide via its Now Pharmacy prescription hubs for free. Registered patients are prompted by text, email or phone when their prescription is due. 

Market research points to a likely proportion of over 60% of patients requiring more than two weeks waiting time for a non-urgent GP appointment. Some 340 million GP appointments are already made in the UK each year. The Dr Now app is set to make waiting times a thing of the past, offering patients a remote appointment to fit in with modern day lives at a time to suit them.

How It Works

Dr Now enables patients to speak to a doctor when you need to, making lengthy waiting times for appointments with your GP a thing of the past. Pre-planned consultations can be arranged for a time to suit the patient, ensuring their hectic working schedule and social life remain hassle-free. The multi-platform telehealth app lets patients speak to a male or female doctor of your choice at the touch of a button. This gives patients access to the diagnosis of a fully qualified GP on the move or from the comfort of your own home, through written or video-based remote video consultation. 

Once patients received their online diagnosis, their medication can be delivered to either their home address or office, with delivery during working hours easy to arrange. Dr Now provides the option of guaranteed next day delivery of private prescriptions and medicines, with those living in London eligible to receive their medication within 1 to 4 hours of diagnosis by a special courier service.

Led by Dr Andrew J Thornber, a doctor of medicine with over 20 years of practicing experience, the Dr Now team is trained in effective ways of providing diagnosis through remote appointments, with a strict security system maintaining patient privacy and safety.

“We are delighted by the NHS England decision to allow patients to use our platform for the time-efficient dispensing and delivery of their medications. This ensures that patients enjoy the freedom to choose the supply chain that suits them best without incremental costs to themselves,” said Savvas Neophytou, Co-founder, CEO. 

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Paradigm Shift in Diabetes Care with Studio Clinics: Q&A with Reach7 Founder Chun Yong

Most-Read

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

2019 MedTech Breakthrough Award Category Winners Announced

MedTech Breakthrough Announces 2025 MedTech Breakthrough Award Winners

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |